Clinical Study
Clinical Outcome of Eradication Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma according to H. pylori Infection Status
Table 1
Baseline characteristics of H. pylori-positive and H. pylori-negative gastric mucosa-associated lymphoid tissue lymphoma patients.
| Variables | H. pylori+ () | H. pylori− () | P value |
| Mean age (SD | 58.9 (11.5) | 58.5 (6.7) | 0.651 | Gender (%) | | | 0.051 | Male | 14 (33) | 8 (67) | | Female | 28 (67) | 4 (33) | | Site of lesion (%) | | | 0.001 | Proximal | 23 (55) | 4 (33) | | Distal | 15 (36) | 2 (17) | | Both | 4 (9) | 6 (50) | | Number of lesions (%) | | | 0.046 | Single | 22 (52) | 2 (17) | | Multiple | 20 (48) | 10 (83) | | Endoscopic finding (%) | | | 0.356 | Superficial type | 37 (88) | 9 (75) | | Advanced cancer-like type | 5 (12) | 3 (25) | | Clinical stage (%) | | | 0.067 | I | 40 (95) | 9 (75) | | II or more | 2 (5) | 3 (25) | |
|
|
Cardia, fundus, high body, or midbody. Low body, angle, or antrum. SD: standard deviation; H. pylori: Helicobacter pylori.
|